Clinical Trial Quality: “Good Enough” Isn’t Good Enough For Patients

Fecha de publicación: 2 de octubre de 2026, 14:46

Settling for “good enough” undermines clinical trial quality in drug development and risks trial failure and regulatory rejection. Here’s what pursuing greatness actually requires.